DarshanTalks Podcast

325 Jaksot

1. What a Clinical Trial Transparency Program Is (and Why You Need One)

   Julkaistiin: 24.11.2020
2. Getting Health Insurance as an Entrepreneur: An Interview With Health Law Expert Kenneth White

   Julkaistiin: 19.11.2020
3. Clinical Trial Transparency Strategy: 6 Things to Consider

   Julkaistiin: 17.11.2020
4. How the FDA Conducts a Clinical Trial Inspection: An Interview With Former FDA Inspector Patrick Stone

   Julkaistiin: 12.11.2020
5. 6 Components of a Clinical Trial Transparency Program

   Julkaistiin: 6.11.2020
6. Starting a Clinical Research Site: An Interview With Kelly Willenberg

   Julkaistiin: 29.10.2020
7. Clinical Trials and Death: An Interview With Bioethicist Peter Koch

   Julkaistiin: 22.10.2020
8. When Do I Need My First Trademark: An Interview With Donna Tobin

   Julkaistiin: 15.10.2020
9. HIPAA and Digital Health Mistakes: An Interview With Shannon Hartsfield

   Julkaistiin: 8.10.2020
10. MHRA’s Developing Impact on Transparency: An Interview With Nirpal Virdee

    Julkaistiin: 2.10.2020
11. Diversity in the Biosciences – An Interview With Tia Lyles-Williams, MRSc

    Julkaistiin: 25.9.2020
12. What Verily’s Reinsurance Platform Means for Healthcare: An Interview With Kenneth White

    Julkaistiin: 18.9.2020
13. Transparency

    Julkaistiin: 8.9.2020
14. Coverage Analysis in Clinical Trials: An Interview with Kelly Willenberg

    Julkaistiin: 4.9.2020
15. Bioethics & AR/VR

    Julkaistiin: 27.8.2020
16. Cannabis: FDA Guidance

    Julkaistiin: 20.8.2020
17. The Future of 503B Pharmacies: An Interview With Syed Saleem

    Julkaistiin: 12.8.2020
18. Pharma and the F.I.R.E. Movement

    Julkaistiin: 6.8.2020
19. The US Privacy Data Shield: Is Your GDPR Compliance Plan Ruined?

    Julkaistiin: 31.7.2020
20. Auditing, Artificial Intelligence and Augmenting Pharmacist Options: An Interview With Former FDA Auditor Patrick Stone

    Julkaistiin: 23.7.2020